Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_
_x000D_
#What Is the Estimated Industry Valuation for the Gastric Cancer Diagnostic Sector?#_x000D_
The market for gastric cancer diagnosis has seen significant growth in the past few years. From $2.59 billion in 2024, it is expected to increase to $2.78 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The growth in previous years can be linked to factors such as a rise in cases of helicobacter pylori infections, heightened awareness of gastric cancer symptoms, increased instances of gastric cancer in older populations, a rise in consumption of smoked and preserved foods, and an increase in the application of diagnostic screening in populations considered high-risk._x000D_
_x000D_
The market size of gastric cancer diagnosis is poised for robust expansion in the coming years, projected to surge to $3.63 billion in 2029 with a compound annual growth rate (CAGR) of 6.9%. Factors contributing to the growth within the forecasted period include enhanced demand for preemptive detection and screening initiatives, stepping up of educational campaigns to prevent gastric cancer, the increasing application of personalized medicinal methods, ongoing improvements in healthcare facilities in newly emergent economies, and a heightened emphasis on quick and non-invasive diagnostic procedures. Key trends throughout the forecasted period encompass advancements in molecular diagnostics technology, the formulation of biomarker panels for more precise diagnosis, the invention of portable devices for point-of-care testing, the conceptualization of less invasive diagnostic tools, and an amalgamation of various imaging methodologies._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=27291&type=smp_x000D_
_x000D_
#What Forces Are Driving The Growth Of The Gastric Cancer Diagnostic Market?#_x000D_
The escalating number of gastric cancer cases is projected to spur the expansion of the gastric cancer diagnostic market in the future. Gastric cancer consists of a hazardous tumor in the stomach lining that can aggressively grow, developing a mass that can breach adjacent tissues and disseminate to varying parts of the body. This surge in gastric cancer prevalence is associated with unwholesome eating habits where consuming high amounts of salted, smoked, and processed food can escalate damage to the stomach lining and amplify cancer risk. Diagnostics for gastric cancer support the early recognition of harmful lesions, thus, ensuring timely therapy and better prognosis for patients. They bolster clinical efficacy by producing prompt and precise results, thereby bolstering superior disease administration. As an illustration, the American Cancer Society, a nonprofit organization based in the US, stated in May 2024 that newly diagnosed stomach cancer cases surged to 26,890 in 2024, a rise from 26,500 cases in 2023. Thus, this escalating trend in gastric cancer cases is fueling the expansion of the gastric cancer diagnostic market._x000D_
_x000D_
#How Is The Gastric Cancer Diagnostic Industry Segmented Across Key Parameters?#_x000D_
The gastric cancer diagnostic market covered in this report is segmented_x000D_
_x000D_
1) By Diagnostic Type: Endoscopy, Imaging, Biopsy, Laboratory Tests, Biomarker-Based Testing_x000D_
2) By Product: Reagents And Consumables, Instruments_x000D_
3) By Technology: Molecular Diagnostics, Immunoassays, Next-Generation Sequencing, Other Technologies_x000D_
4) By Application: Early Diagnosis, Screening, Monitoring_x000D_
5) By End User: Hospitals, Clinics, Diagnostic Laboratories, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Endoscopy: Conventional Endoscopy, Chromoendoscopy, Narrow Band Imaging, Confocal Laser Endomicroscopy, Capsule Endoscopy_x000D_
2) By Imaging: Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound_x000D_
3) By Biopsy: Forceps Biopsy, Needle Biopsy, Endoscopic Ultrasound-Guided Biopsy, Laparoscopic Biopsy_x000D_
4) By Laboratory Tests: Blood Tests, Stool Tests, Urea Breath Test, Serology_x000D_
5) By Biomarker-Based Testing: Genetic Testing, Protein Biomarker Testing, Circulating Tumor DNA Testing, Microribonucleic Acid Testing_x000D_
_x000D_
#What Notable Trends Are Shaping The Direction Of The Gastric Cancer Diagnostic Market?#_x000D_
Significant players in the gastric cancer diagnostic market are concentrating on creating innovative diagnostic solutions like AI-based endoscopic diagnostic support devices to bolster early detection and precision. These AI-driven tools help in identifying and evaluating gastrointestinal anomalies during endoscopy. For example, in March 2024, AI Medical Service Inc., a company based in Japan that specializes in medical technology, introduced GastroAI-model G, an endoscopic diagnostic support system powered by AI. This system benefits gastroenterologists during endoscopy by real-time video image analysis to pinpoint potential malignant lesions. It employs deep learning to spot suspicious regions indicative of early stage gastric cancer, which might necessitate biopsy or additional scrutiny. When such lesions are found, the system promptly alerts the doctor by marking the area with a rectangle on the endoscopy screen, boosting diagnostic precision and facilitating early detection of cancer._x000D_
_x000D_
#Which Companies Currently Dominate The Competitive Landscape In The Gastric Cancer Diagnostic Industry?#_x000D_
Major companies operating in the gastric cancer diagnostic market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMérieux SA, Qiagen N.V., DiaSorin S.p.A, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Foundation Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Fujirebio Inc., MiRXES Pte Ltd., BIOCEPT Inc., Pillar Biosciences Inc. _x000D_
_x000D_
#Get The Full Report Here:#_x000D_
_x000D_
#Which Geographic Regions Are Driving Demand In The Gastric Cancer Diagnostic Market?#_x000D_
North America was the largest region in the gastric cancer diagnostic market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=27291&type=smp_x000D_
_x000D_
#About The Business Research Company:#_x000D_
_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model